All subcategories » Health Technology Assessment Report
The Effect Of Telerehabilitation On Quality Of Life, Anxiety And Depression In Children With Cystic Fibrosis And Caregivers: A Single-Blind Randomized Trial.
HTA - Health Technology Assessment Report
Details- 2022
- Kenis-Coskun Ö
Lumacaftor/ivacaftor in people with cystic fibrosis with an A455E-CFTR mutation.
HTA - Health Technology Assessment Report
Details- 2021
- Berkers G
Long-term amikacin liposome inhalation suspension in cystic fibrosis patients with chronic P. aeruginosa infection.
HTA - Health Technology Assessment Report
Details- 2021
- Bilton D
Riociguat for the treatment of Phe508del homozygous adults with cystic fibrosis.
HTA - Health Technology Assessment Report
Details- 2021
- Derichs N
The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover study (AZTEC-CF).
HTA - Health Technology Assessment Report
Details- 2021
- Frost F
Comparison of biosimilar Tigerase and Pulmozyme in long-term symptomatic therapy of patients with cystic fibrosis and severe pulmonary impairment (subgroup analysis of a Phase III randomized open-label clinical trial (NCT04468100)).
HTA - Health Technology Assessment Report
Details- 2021
- Amelina EL